Orphan Drugs for Rare Diseases Gain Popularity With Pharmaceutical Companies
Wednesday, January 30, 2013 - 22:30
in Health & Medicine
A drug for short bowel syndrome, intended for fewer than 5,000 people, is aimed at the orphan drug market, where companies can charge a premium to treat overlooked diseases.